Citadel Advisors’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,197
Closed -$12K 15867
2022
Q3
$12K Sell
3,197
-4,283
-57% -$30.4K ﹤0.01% 12244
2022
Q2
$47K Buy
+7,480
New +$69.8K ﹤0.01% 11978
2022
Q1
Sell
-1,073
Closed -$17K 15079
2021
Q4
$17K Buy
+1,073
New +$22.7K ﹤0.01% 13609
2021
Q3
Sell
-4,334
Closed -$130K 15063
2021
Q2
$151K Buy
4,334
+1,173
+37% +$46.6K ﹤0.01% 12502
2021
Q1
$152K Buy
3,161
+2,084
+194% +$121K ﹤0.01% 12016
2020
Q4
$52K Buy
+1,077
New +$40.5K ﹤0.01% 10554
2020
Q2
Sell
-1,738
Closed -$69.3K 10740
2020
Q1
$41K Buy
+1,738
New +$41.6K ﹤0.01% 9113
2019
Q4
Sell
-1,213
Closed -$13K 9987
2019
Q3
$13K Buy
+1,213
New +$10.8K ﹤0.01% 9018
2019
Q1
Sell
-1,790
Closed -$15K 10084
2018
Q4
$15K Buy
1,790
+1,059
+145% +$18.6K ﹤0.01% 8846
2018
Q3
$17K Sell
731
-1,704
-70% -$64.8K ﹤0.01% 9042
2018
Q2
$121K Buy
2,435
+1,274
+110% +$63.1K ﹤0.01% 8159
2018
Q1
$53K Sell
1,161
-1,099
-49% -$55.2K ﹤0.01% 7913
2017
Q4
$103K Buy
+2,260
New +$120K ﹤0.01% 7421
2017
Q2
Sell
-980
Closed -$73K 8261
2017
Q1
$73K Buy
+980
New +$109K ﹤0.01% 6957

Other funds holding NH

Citadel Advisors's NH Position: Q4 2022 in Review

Citadel Advisors sold out of NantHealth, Inc (NH) in Q4 2022, closing a stake of 3,197 shares — an estimated $12K sold.

Citadel Advisors first reported a position in NH in Q1 2017 and held it in 14 quarters. The position peaked at $152K in Q1 2021. 18 funds tracked by Wall St. Rank hold NH as of Q4 2022.

  • Citadel Advisors reported no remaining NantHealth, Inc position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 3,197 NantHealth, Inc shares in Q4 2022, an estimated $12K.
  • Citadel Advisors first reported a position in NantHealth, Inc in Q1 2017 and held it in 14 quarters.
  • Citadel Advisors's NantHealth, Inc position peaked at $152K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.